{
  "id": 3930357,
  "title": "Novogene establishes first Australian genomics laboratory at Cabrini Health",
  "url": "https://urgent.news/2026/08/28/novogene-establishes-first-australian-genomics-laboratory-at-cabrini",
  "topic": "business",
  "section": "Business",
  "published": "2026-08-28T09:14:37.000Z",
  "source": {
    "name": "Vietnam Investment Review",
    "slug": "vietnam-investment-review",
    "url": "https://vir.com.vn/novogene-establishes-first-australian-genomics-laboratory-at-cabrini-health-159648.html"
  },
  "original_language": "en",
  "account": "Melbourne, Australia - Global multi-omics firm Novogene is setting up its inaugural Australian laboratory at Cabrini Health, introducing advanced genomic resources to Australian patients and researchers. This strategic placement within Cabrini Malvern's clinical and cancer research hub will facilitate quicker genomic test results, enabling faster cancer treatment decisions and expedited access to personalized therapies. The joint laboratory is set to commence operations in 2027, marking Novogene's presence as Australia's first genomics lab co-located within a private hospital. This expansion significantly bolsters Victoria's precision medicine capabilities, offering industry-leading expertise, technologies, and workflows in high-throughput sequencing and multi-omics. Cabrini Health's cancer services conduct around 30,000 treatments and 4,000 diagnoses annually, while its clinical trials program grants patients access to innovative therapies across approximately 100 active trials. By integrating genomic testing into the clinical setting, Novogene's laboratory aims to expedite the transition from biopsy to genomic results, streamlining clinical decision-making and treatment initiation. Professor Gary Richardson, Group Director of Cabrini Research, emphasized the immediate and long-term benefits for cancer patients, particularly those with rare and complex conditions, as it will provide faster access to potentially life-saving treatments. The laboratory's establishment is made possible through significant investments, including a $10 million grant from the PMF Foundation and a $5 million Australian Government grant, dedicated to establishing a precision oncology program. Novogene's Vice President, Justin Lee, lauded Cabrini Health's leadership in cancer care and research, noting that its proximity to universities and healthcare networks makes it an ideal location for Novogene's first Australian laboratory. Lee highlighted the firm's commitment to Australia and its intention to strengthen collaboration and accelerate the translation of scientific discoveries into clinical impact. Novogene's Country Director, Dr. Olivia He, expressed that the Melbourne laboratory will bolster the company's capacity to support healthcare and research partners, enabling faster, more responsive support and deeper collaboration as precision medicine evolves.",
  "summary": "Multi omics provider Novogene partnered with Cabrini Health in Melbourne to build its first Australian laboratory accelerating diagnostic turnover times for local oncology researchers and patients",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}